PIQ-PHARMA’s anti-epileptic portfolio has been expanded with the addition of Lacolexid® tablets.

PIQ-PHARMA`s anti-epileptic portfolio has been expanded with the addition of Lacolexid® film-coated tablets, available in 50 mg, 100 mg, 150 mg, and 200 mg strengths (INN: Lacosamide).

Lacolexid® is indicated for use in adults, adolescents, and children over 4 years of age for the treatment of epilepsy as:

• monotherapy or adjunctive therapy for partial seizures, with or without secondary generalization;
• adjunctive therapy for primary generalized tonic-clonic seizures in idiopathic generalized epilepsy.

Lacolexid® is available by prescription only.

Contraindications exist. Please read the instructions for use and consult a healthcare professional before use.